HUE052468T2 - Arginázgátlók és terápiás alkalmazásaik - Google Patents
Arginázgátlók és terápiás alkalmazásaikInfo
- Publication number
- HUE052468T2 HUE052468T2 HUE17721137A HUE17721137A HUE052468T2 HU E052468 T2 HUE052468 T2 HU E052468T2 HU E17721137 A HUE17721137 A HU E17721137A HU E17721137 A HUE17721137 A HU E17721137A HU E052468 T2 HUE052468 T2 HU E052468T2
- Authority
- HU
- Hungary
- Prior art keywords
- therapeutic applications
- arginase inhibitors
- arginase
- inhibitors
- therapeutic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/04—Esters of boric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662331550P | 2016-05-04 | 2016-05-04 | |
| PL417066A PL417066A1 (pl) | 2016-05-04 | 2016-05-04 | Inhibitory arginazy oraz ich zastosowania terapeutyczne |
| US201762444669P | 2017-01-10 | 2017-01-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE052468T2 true HUE052468T2 (hu) | 2021-04-28 |
Family
ID=60190450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE17721137A HUE052468T2 (hu) | 2016-05-04 | 2017-05-02 | Arginázgátlók és terápiás alkalmazásaik |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US10391077B2 (hu) |
| EP (1) | EP3452485B1 (hu) |
| JP (1) | JP6971477B2 (hu) |
| KR (1) | KR102374788B1 (hu) |
| CN (1) | CN109415387B (hu) |
| AU (1) | AU2017259887B2 (hu) |
| BR (1) | BR112018072545B1 (hu) |
| CA (1) | CA3022482C (hu) |
| CL (1) | CL2018003132A1 (hu) |
| CO (1) | CO2018013077A2 (hu) |
| DK (1) | DK3452485T3 (hu) |
| ES (1) | ES2834065T3 (hu) |
| HR (1) | HRP20201821T1 (hu) |
| HU (1) | HUE052468T2 (hu) |
| IL (1) | IL262387B (hu) |
| LT (1) | LT3452485T (hu) |
| MX (1) | MX378806B (hu) |
| PE (1) | PE20181924A1 (hu) |
| PH (1) | PH12018501976A1 (hu) |
| PL (2) | PL417066A1 (hu) |
| SA (1) | SA518400356B1 (hu) |
| SG (1) | SG11201807974QA (hu) |
| SI (1) | SI3452485T1 (hu) |
| WO (1) | WO2017191130A2 (hu) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2794006T3 (es) | 2010-10-26 | 2020-11-17 | Mars Inc | Inhibidores de arginasa como agentes terapéuticos |
| US10070649B2 (en) | 2013-01-30 | 2018-09-11 | Agrofresh Inc. | Volatile applications against pathogens |
| US11039617B2 (en) | 2013-01-30 | 2021-06-22 | Agrofresh Inc. | Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness |
| PL3368541T3 (pl) | 2015-10-30 | 2020-11-02 | Calithera Biosciences, Inc. | Kompozycje i sposoby hamowania aktywności arginazy |
| EP3426029B1 (en) | 2016-03-07 | 2023-08-30 | AgroFresh Inc. | Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops |
| PL417066A1 (pl) * | 2016-05-04 | 2017-11-06 | Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością | Inhibitory arginazy oraz ich zastosowania terapeutyczne |
| PL3559009T3 (pl) | 2016-12-22 | 2021-10-25 | Calithera Biosciences, Inc. | Kompozycje i sposoby hamowania aktywności arginazy |
| CN111712302B (zh) | 2018-02-17 | 2023-09-19 | 阿斯利康(瑞典)有限公司 | 精氨酸酶抑制剂及其使用方法 |
| CA3091805A1 (en) * | 2018-03-05 | 2019-09-12 | Arcus Biosciences, Inc. | Arginase inhibitors |
| US12215116B2 (en) | 2018-03-13 | 2025-02-04 | Merck Sharp & Dohme Llc | Arginase inhibitors and methods of use |
| CA3094939A1 (en) * | 2018-03-29 | 2019-10-03 | Oncoarendi Therapeutics S.A. | Dipeptide piperidine derivatives |
| EP3810615A4 (en) | 2018-06-20 | 2022-03-30 | Merck Sharp & Dohme Corp. | ARGINASE INHIBITORS AND METHODS OF USE |
| CA3120196A1 (en) | 2018-11-16 | 2020-05-22 | Arcus Biosciences, Inc. | Inhibitors of arg1 and/or arg2 |
| EP3897622A4 (en) | 2018-12-18 | 2022-09-28 | Merck Sharp & Dohme Corp. | Arginase inhibitors and methods of use |
| JP2023502182A (ja) | 2019-11-12 | 2023-01-20 | ナミ セラピューティクス， インコーポレイテッド | がんの処置において有用なｉｄｏアンタゴニストプロドラッグを含有する製剤化および／または共製剤化されたリポソーム組成物およびその方法 |
| WO2021141751A1 (en) * | 2020-01-07 | 2021-07-15 | Merck Sharp & Dohme Corp. | Arginase inhibitors and methods of use |
| TW202228720A (zh) * | 2020-12-22 | 2022-08-01 | 波蘭商昂科艾倫迪治療法股份公司 | 精胺酸酶抑制劑及其使用方法 |
| AU2024243114A1 (en) | 2023-04-06 | 2025-10-09 | Molecure S.A. | Process for the production of (1r,2s,5r)-1-amino-5-[2-(dihydroxyboranyl)ethyl]-2-[(dimethylamino)methyl]cyclohexane-1-carboxylic acid |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ241954A (en) | 1991-03-15 | 1994-01-26 | Amgen Inc | Compositions of g-csf for pulmonary administration. |
| US5451569A (en) | 1994-04-19 | 1995-09-19 | Hong Kong University Of Science And Technology R & D Corporation Limited | Pulmonary drug delivery system |
| EP1049660A1 (en) * | 1997-10-10 | 2000-11-08 | The Trustees Of The University Of Pennsylvania | Compositions and methods for inhibiting arginase activity |
| EP1604977A1 (en) | 2004-06-02 | 2005-12-14 | Faust Pharmaceuticals | CIS pyrrolidinyl derivatives and their uses |
| EP1604978A1 (en) | 2004-06-02 | 2005-12-14 | Faust Pharmaceuticals | Trans pyrrolidinyl derivatives and their pharmaceutical uses |
| ES2633094T3 (es) | 2006-11-21 | 2017-09-19 | Rijksuniversiteit Groningen | Uso de inhibidores de arginasa en el tratamiento del asma y rinitis alérgica |
| PL2389352T3 (pl) | 2009-01-26 | 2019-10-31 | Univ Pennsylvania | Inhibitory arginazy oraz sposoby zastosowania |
| CN103068830B (zh) * | 2010-04-22 | 2016-06-29 | 马尔斯公司 | 精氨酸酶抑制剂及其治疗应用 |
| WO2012025155A1 (en) | 2010-08-26 | 2012-03-01 | Novartis Ag | Hydroxamate-based inhibitors of deacetylases |
| ES2794006T3 (es) * | 2010-10-26 | 2020-11-17 | Mars Inc | Inhibidores de arginasa como agentes terapéuticos |
| US8894970B2 (en) | 2010-12-31 | 2014-11-25 | Corridor Pharmaceuticals, Inc. | Arginase inhibitors and methods of use thereof |
| AU2012326109A1 (en) | 2011-10-19 | 2014-05-29 | Mars, Incorporated | Inhibitors of arginase and their therapeutic applications |
| US9200011B2 (en) * | 2012-04-18 | 2015-12-01 | Mars, Incorporated | Ring constrained analogs as arginase inhibitors |
| PL2872515T3 (pl) | 2012-07-13 | 2017-05-31 | Janssen Sciences Ireland Uc | Puryny makrocykliczne do leczenia infekcji wirusowych |
| PL410665A1 (pl) | 2014-12-29 | 2016-07-04 | Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością | Inhibitory arginazy oraz ich zastosowania terapeutyczne |
| KR20180021117A (ko) | 2015-06-23 | 2018-02-28 | 칼리테라 바이오사이언시즈, 인코포레이티드 | 아르기나제 활성 억제를 위한 조성물 및 방법 |
| PL3368541T3 (pl) | 2015-10-30 | 2020-11-02 | Calithera Biosciences, Inc. | Kompozycje i sposoby hamowania aktywności arginazy |
| PL417066A1 (pl) * | 2016-05-04 | 2017-11-06 | Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością | Inhibitory arginazy oraz ich zastosowania terapeutyczne |
| MX2019005402A (es) | 2016-11-08 | 2019-12-05 | Calithera Biosciences Inc | Terapias de combinacion del inhibidor de arginasa. |
| WO2019145453A1 (en) | 2018-01-28 | 2019-08-01 | Universite De Geneve | Arginase suppression for cancer treatment |
-
2016
- 2016-05-04 PL PL417066A patent/PL417066A1/pl unknown
-
2017
- 2017-05-02 SG SG11201807974QA patent/SG11201807974QA/en unknown
- 2017-05-02 HR HRP20201821TT patent/HRP20201821T1/hr unknown
- 2017-05-02 LT LTEP17721137.2T patent/LT3452485T/lt unknown
- 2017-05-02 PE PE2018002300A patent/PE20181924A1/es unknown
- 2017-05-02 US US15/584,193 patent/US10391077B2/en active Active
- 2017-05-02 JP JP2018556824A patent/JP6971477B2/ja active Active
- 2017-05-02 HU HUE17721137A patent/HUE052468T2/hu unknown
- 2017-05-02 CA CA3022482A patent/CA3022482C/en active Active
- 2017-05-02 EP EP17721137.2A patent/EP3452485B1/en active Active
- 2017-05-02 KR KR1020187034423A patent/KR102374788B1/ko active Active
- 2017-05-02 DK DK17721137.2T patent/DK3452485T3/da active
- 2017-05-02 WO PCT/EP2017/060413 patent/WO2017191130A2/en not_active Ceased
- 2017-05-02 PL PL17721137T patent/PL3452485T3/pl unknown
- 2017-05-02 MX MX2018013387A patent/MX378806B/es unknown
- 2017-05-02 SI SI201730505T patent/SI3452485T1/sl unknown
- 2017-05-02 BR BR112018072545-5A patent/BR112018072545B1/pt active IP Right Grant
- 2017-05-02 CN CN201780041841.9A patent/CN109415387B/zh active Active
- 2017-05-02 ES ES17721137T patent/ES2834065T3/es active Active
- 2017-05-02 AU AU2017259887A patent/AU2017259887B2/en active Active
-
2018
- 2018-09-13 PH PH12018501976A patent/PH12018501976A1/en unknown
- 2018-10-15 IL IL262387A patent/IL262387B/en unknown
- 2018-11-01 SA SA518400356A patent/SA518400356B1/ar unknown
- 2018-11-05 CL CL2018003132A patent/CL2018003132A1/es unknown
- 2018-12-03 CO CONC2018/0013077A patent/CO2018013077A2/es unknown
-
2019
- 2019-08-14 US US16/540,747 patent/US10912755B2/en active Active
-
2021
- 2021-02-05 US US17/168,291 patent/US12053451B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE052468T2 (hu) | Arginázgátlók és terápiás alkalmazásaik | |
| HUE054159T2 (hu) | HPK1 gátlók és azok alkalmazási módja | |
| IL259441A (en) | Materials and methods for treatment of titin-based myopathies and other titinopaties | |
| DK3448386T3 (da) | Isoquinolin-3-ylcarboxamider og fremstilling og anvendelse deraf | |
| EP3526222A4 (en) | TYK2 INHIBITORS AND THEIR USES | |
| EP3528816A4 (en) | TYK2 INHIBITORS AND USES THEREOF | |
| HUE046756T2 (hu) | Benzoxazepin-oxazolidinon vegyületek és azok alkalmazási módszerei | |
| IL280863A (en) | Autotaxin inhibitors and uses thereof | |
| HUE055755T2 (hu) | Szulfonolkarmabidok és rokon vegyületeik valamint felhasználásuk | |
| DK3283106T3 (da) | Terapeutiske antistoffer og anvendelser deraf | |
| DK3354282T3 (da) | Glycan-terapeutiske midler og relaterede fremgangsmåder deraf | |
| DK3357513T3 (da) | Farmaceutisk sammensætning og anvendelse deraf | |
| HUE054347T2 (hu) | MK2 inhibitorok és azok alkalmazásai | |
| PT3319612T (pt) | Oxisteróis e métodos de utilização dos mesmos | |
| PL3240777T3 (pl) | Inhibitory arginazy oraz ich zastosowania terapeutyczne | |
| HUE063120T2 (hu) | LRRC33-inhibitorok és alkalmazásuk | |
| DK3490988T3 (da) | Ny forbindelse og fremgangsmåde | |
| DK3532459T3 (da) | Lsd1-hæmmere og medicinske anvendelser deraf | |
| HUE054093T2 (hu) | Anti-HtrA1 antitestek és azok alkalmazási eljárásai | |
| DK3474883T3 (da) | Komplementinhibitorer og anvendelser deraf | |
| KR20180084747A (ko) | Galgt2 유전자 치료 방법 및 물질 | |
| HUE049409T2 (hu) | Alkinilpiridin-prolil-hidroxiláz inhibitor és annak elõállítási eljárása és gyógyászati alkalmazása | |
| HUE058289T2 (hu) | Brómdomén és extraterminális protein inhibitor kombinációs terápia | |
| DK3321279T3 (da) | Exenatidmodificeringsmiddel og anvendelse deraf | |
| EP3526186A4 (en) | SUBSTITUTED HYDROXY STYLENE AND THEIR THERAPEUTIC APPLICATIONS |